Laird Norton Trust Company LLC decreased its holdings in Comerica Incorporated (NYSE: CMA) during the third quarter, as stated in the most recent filing that the company has made with the Securities and Exchange Commission (SEC). Following the transaction during the period, the fund was left in possession of 3,319 shares of the company’s stock after selling 3,352 shares of the company’s stock. The most recent report submitted to the Securities and Exchange Commission by the Laird Norton Trust Company LLC indicated that their investment in Comerica had a value of 238,000 dollars.
Several other notable investors have recently adjusted the number of shares in the company they own. The amount of $27,000 was spent by Ronald Blue Trust Inc. to acquire a new position in Comerica during the second quarter of the year. Oakworth Capital Inc.
Increased its total ownership of Comerica to almost 100 percent during the second quarter by purchasing approximately $34,000 worth of additional stock.
During the second quarter, Evoke Wealth LLC achieved a 38.0% increase in the amount of Comerica stock it owned.
Evoke Wealth LLC is now the owner of a total of 494 shares, with a market cap of $36,000. This is because the company made an additional purchase of 136 shares during the relevant period. Comerica received an investment from Chilton Capital Management LLC totaling approximately $47,000 during the second quarter of the fiscal year.
Last but not least, Hexagon Capital Partners LLC increased the percentage of its investment in Comerica by 125.3% during the third quarter.
After purchasing an additional 501 shares during the preceding quarter, Hexagon Capital Partners LLC now holds 901 shares of the financial services provider’s stock. The current market value of these shares is $64,000.
Most of the stock is owned by hedge funds and other institutional investors, which accounts for 81.91% of the total.
Multiple research companies have provided their most recent feedback on the CMA in recent days. Comerica received an ” underweight ” rating from Barclays, which led to the firm lowering its price objective for its stock from $87.00 to $85.00.
A research note distributed on January 3 informed the general public about these alterations. Wedbush rated the company as “outperforming” in a research report published on Thursday, October 20, and decreased their price objective on Comerica stock from $95.00 to $84.00.
In addition, the report recommended that the company “outperform” its competitors.
DA Davidson upgraded Comerica from a “buy” rating to a “strong-buy” rating. He increased their price target from $80.00 to $82.00 in a research report made available to the public on Friday, January 20. The price target that Wolfe Research has set for Comerica stock has increased from $79.00 to $80.00, as stated in a research note published on Thursday, December 1.
Last but not least, Morgan Stanley lowered its “equal weight” rating and price objective on Comerica shares, dropping them from $89.00 to $85.00 in a research note published on December 15. One equity research analyst has suggested selling the stock, five analysts have stated that they will maintain their position in the stock, and sixteen analysts have indicated that they will purchase additional company shares.
According to the data that Bloomberg provided, the organization is currently rated as a “Moderate Buy,” and it has established an average price goal of $83.02 for the foreseeable future.
The NYSE CMA started the trading day on Thursday with a price per share of 71.52 dollars.
A few values can be used in this calculation, including a debt-to-equity ratio of 0.63, a current ratio of 0.85, and a quick ratio of 0.85.
During the past year, the price of Comerica Incorporated has fluctuated between $62.83 and $102.09. The lowest point during that period was 62.83 dollars. The moving average for the stock over the past 50 days is $67.86, and the moving average for the past 200 days is $73.32, respectively. The company has a PE ratio of 8.44, a PEG ratio of 2.25, and its beta value is currently 1.18.
Its market capitalization is currently sitting at $9.37 billion at this time.
On the 19th of this month, Comerica (NYSE: CMA) published the most recent version of its earnings report. The financial services company reported earnings per share for the quarter of $2.58, which is $0.02 higher than the market research-derived consensus estimate of $2.56. The consensus estimate was derived from the company’s earnings for the previous quarter. The revenue the company brought in for the quarter was $1.02 billion, even though market watchers predicted that the company would bring in $1.01 billion in revenue for the quarter. Comerica had a return on equity of 20.75 percent, and the company’s net margin was 30.72% of the company’s revenue.
During the same period the previous year, the corporation posted a profit of 1.66 dollars per share it had outstanding.
According to the consensus among market experts, Comerica Incorporated is expected to achieve earnings of $9.63 per share in 2018.
Additionally, the corporation has only very recently announced and started paying out a quarterly dividend, which was done so on the first day of each month. Record holders of the company’s stock were eligible to receive a dividend payment of $0.68 on December 15. This payment was made. The dividend payment was made on Wednesday, December 14, the month of December, and the day of the week. This equates to a yield of 3.8 percent each quarter and a dividend payment of 2.72 each year. The percentage of dividends distributed by Comerica amounts to 32.11 percent.
Because it has several different subsidiaries, Comerica Incorporated can provide its customers with diverse financial products and services. The company conducts its daily operations through the following business divisions: commercial banking, retail banking, wealth management, and finance. The Commercial Bank division provides small and middle-market businesses, multinational corporations, and governmental entities with commercial loans and lines of credit, deposits, cash management, capital market products, international trade financing, letters of credit, foreign exchange management services, and loan syndication services. These products and services are under the heading “Commercial Banking.”